MBX Biosciences, Inc. (MBX)
34.79
-2.47
(-6.63%)
USD |
NASDAQ |
Feb 20, 16:00
34.12
-0.67
(-1.93%)
After-Hours: 20:00
MBX Biosciences Total Liabilities (Quarterly) : 12.54M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 117.67B |
| Madrigal Pharmaceuticals, Inc. | 656.90M |
| Insmed, Inc. | 1.526B |
| UnitedHealth Group, Inc. | 207.88B |
| Aardvark Therapeutics, Inc. | 10.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 400.08M |
| Shareholders Equity (Quarterly) | 387.54M |
| Debt to Equity Ratio | 0.0016 |
| Current Ratio | 32.95 |
| Net Debt Paydown Yield | -0.01% |